NCT06001684 2024-01-03
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 1 Unknown
Clinical Trials
11 trialsNCT04190823 2023-11-27
A Study of RC98 in Subjects With Advanced Malignant Solid Tumors
RemeGen Co., Ltd.
Phase 1 Unknown
NCT05149027 2021-12-08
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 1 Unknown
NCT04972422 2021-09-05
A Phase 1b Study of ZN-c3 in Chinese Subjects
Zentera Therapeutics HK Limited
Phase 1 Unknown
NCT02435927 2021-04-28
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
National Cancer Centre, Singapore
Phase 1 Unknown
NCT04727164 2021-01-29
Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 1 Unknown
NCT03950297 2020-04-03
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1 Unknown
NCT03503604 2018-04-20
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
SuZhou Stainwei Biotech Inc.
Phase 1 Unknown
NCT02020226 2016-06-02
A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
Threshold Pharmaceuticals
Phase 1 Unknown
NCT02395068 2015-08-19
Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
Biotech Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT00818831 2015-01-28
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Quintessence Biosciences, Inc.
Phase 1 Unknown